A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05984784

Recruitment Status : Terminated (Terminated because the sponsor believes that results from Cohort 1 will provide reliable information for further development decision. No safety concerns were noted.)

First Posted : August 9, 2023

Last Update Posted : May 16, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Inmagene LLC

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	April 26, 2024
Actual Study Completion Date :	April 26, 2024

To Top